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Although there are many methods available for inferring copy-number variants (CNVs) from next-generation sequence data, there
remains a need for a system that is computationally efficient but that retains good sensitivity and specificity across all types of CNVs.
Here, we introduce a new method, estimation by read depth with single-nucleotide variants (ERDS), and use various approaches to
compare its performance to other methods. We found that for common CNVs and high-coverage genomes, ERDS performs as well as
the best method currently available (Genome STRiP), whereas for rare CNVs and high-coverage genomes, ERDS performs better than
any available method. Importantly, ERDS accommodates both unique and highly amplified regions of the genome and does so without
requiring separate alignments for calling CNVs and other variants. These comparisons show that for genomes sequenced at high
coverage, ERDS provides a computationally convenientmethod that calls CNVs as well as or better than any currently available method.Introduction
Duplicated and deleted chromosomal regions, known as
copy-number variants (CNVs), are distributed at high
frequency across the entire human genome.1,2 It was
recently shown that such variants (especially deletions)
are relatively depleted in exonic and intronic regions,3 sug-
gesting that genic CNVs are more likely to be pathogenic
than nongenic ones. Moreover, a growing number of
CNVs have been securely identified as risk factors for
many common diseases, in particular neuropsychiatric
diseases4–10 and obesity.11,12
With the rapid development of next-generation se-
quencing (NGS) technologies,13 there is intense interest
in using NGS data to identify and genotype CNVs.14,15
CNVs can be identified by means of specific signatures
that they leave in the aligned sequence data, for example,
changes in read-depth (RD), discordantly mapped read
pairs (RP or paired-end mapping, PEM) or split reads
(SRs) (see comprehensive reviews in Medvedev et al.16
and Alkan et al.17). Significant progress has been made in
the development of calling methods that use different
types of signatures, and each approach has different
strengths and weaknesses and varying computational
requirements. For example, Genome STRiP18 provides
exceptional calling accuracy for common CNVs in low-
coverage samples.15 For the assessment of algorithms in
high-coverage samples, in a HapMap sample, NA12878,
sequenced at ~403 by the 1000 Genomes Project
(1000GP), more than ten approaches were compared
with a ‘‘gold standard’’ data set (GSD)15 (a set of deletions
previously identified for this sample3,19–21). This compar-1Center for Human Genome Variation, Duke University, Durham, NC 27708
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that the false discovery rate (FDR) ranged from 9% to
89%. This varying performance emphasizes the need to
establish a unified detection system that is computa-
tionally efficient and convenient and that retains good
sensitivity and specificity across all types of copy-number
variants, large and small and of various frequencies. The
system should not only detect the presence of a CNV but
also determine its breakpoints. Here we describe an effec-
tive detection system specifically for high-coverage
samples. Named ERDS (estimation by read depth with
single-nucleotide variants [SNVs]), it combines read depth,
paired-end information, and polymorphism data primarily
by using a paired Hidden Markov Model (HMM). Via
different procedures, ERDS can identify CNVs that are in
uniquely mappable regions of the genome as well as those
that are not. The latter category (defined below) is a subset
of regions identified as carrying segmental duplication
(SD) in the UCSC browser. ERDS performs well for both
deletions and duplications in part by combining the
most effective aspects of a number of already-available
routines, in particular integrating information from
different signatures of structural variants (as do CNVer,22
Genome STRiP18 and SV-Finder [Y.H., unpublished data])
and developing specialized routines for handling amplified
regions of the genome (as does mrFAST23).
Material and Methods
Study Subjects
All samples were collected according to local IRB and ethics
committee approval. The Duke University School of Medicine, USA; 2Department of Biostatistics and Bioinformatics, Duke University,
Cancer Institute, Buffalo, NY 14263, USA
.)
y of Human Genetics. All rights reserved.
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Figure 1. ERDS Flow ChartInstitutional Review Board has also reviewed and approved the use
of these samples.Alignment
This step is a standard prerequisite. Raw sequence data were
produced by the Illumina Genome Analyzer HiSeq 2000 pipeline
at the Center for Human Genome Variation’s Genomic Analysis
Facility (Duke University). Paired-end reads were aligned to the
Human Reference Genome (NCBI build 36) with the Burrows-
Wheeler Alignment tool (BWA) version 0.5.5.24 A quality-control
procedure removed potential PCR duplicates with Picard (version
1.29). The file containing all SNVs was generated with the SAM-
tools (version 0.1.7a) pileup and variation filter routines.
We use hg18 coordinates throughout the paper.Algorithm Development in ERDS
We give a brief introduction of the algorithm (Figure 1). More
algorithmic details can be found in Appendix A.
Partition of the Reference Genome into Amplified and Nonamplified
Regions
In NGS, short reads sequenced from repetitive regions can often be
mapped to multiple locations equally well. The mrFAST23 and
mrsFAST25 aligners can efficiently store all possible mapping loca-
tions of reads, making it possible to accurately predict the absolute
copy numbers of regions. However, the resulting alignment data
are not suitable for calling other kinds of variants, meaning that
separate alignment would be required for calling SNVs and struc-
tural variants. We therefore sought to establish a framework to
be able to accurately infer copy-number status even in SD regions
by using data aligned by BWA, which randomly places a read toThe American Journal of Human Geneonly one of the mappable locations
by default. Instead of using a static prede-
fined distinction between SD regions and
unique genomic regions, however, we
sought to divide the genome into regions
that are distinguishable by BWA and those
that are not. We identified such regions by
taking each 1 kb segment of the reference
genome and searching throughout the
remainder of the genome for paralogous
segments. Using simulated reads of length
100 bp, we partitioned the reference
genome into two parts: amplified regions
and nonamplified regions. To do this, we
relied solely upon whether the sequence
from a region was distinguishable by
BWA. The amplified regions (regions not
distinguishable by BWA) correspond to
a subset of the UCSC SD regions (about
one-third by genomic length) that have
nearly identical paralogous regions (iden-
tityR 0.99 in general). The reason to iden-
tify the amplified regions is to determine
whether to call CNVs in a locus-specific
manner or to calculate a genome-wide
sum of copy numbers (absolute copy
numbers) across all paralogous loci inamplified regions. CNVer16 has a similar step of partitioning the
reference to avoid calling locus-specific copy numbers for
paralogous loci.
Estimation of Expected RD
This step is essential to the accuracy of an RD-based method for
both identifying and genotyping (determining the allelic state
of) CNVs. For each sample, we calculated the RD for nonoverlap-
ping sliding windows across the autosomes (200 bp was used in
this study, but window size can be adjusted by the user). We aver-
aged the mapping-quality scores of all bases within a window to
produce an overall mapping-quality score for the window. We
then grouped the windows with non-zero mapping-quality scores
into bins with respect to the G þ C percentage and estimated the
expected RD of the diploid state in each G þ C bin by using an
expectation-maximization (EM) approach.26
Initial Copy-Number Inference
For nonamplified regions, we applied a continuous pairedHMM to
detect CNVs by incorporating both RD data and SNV heterozy-
gosity data. The emission probabilities were estimated with
Poisson models, the transition probabilities were derived from
the Baum-Welch algorithm, and the most-likely copy-number
states for windows were inferred with the Viterbi algorithm.27 At
amplified regions, we summed up the RD of the windows for
each set of indistinguishable regions identified and proceeded to
the genotyping step (see below).
Refinement of Deletions
NGS data present multiple types of signatures that can be used for
CNV detection. Although a method based on a single signature is
conceptually simple, it is difficult for such a method to achieve
both high sensitivity and a low FDR.15 To our knowledge, CNVer,
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multiple signatures to detect CNVs, but the approaches imple-
mented vary. In the ERDS framework, we integrated PEM and
soft-clipping (SC) signatures28 into the RD-based approach to
filter possible false positives, confirm weak RD signals, and
refine the breakpoints of putative deletions, as follows (also see
Appendix A). (1) As the RD (or PEM)-based approach becomes
less (or more) reliable for smaller deletions16,17, we set a threshold
of 10 kb above which all RD-predicted CNVs are accepted but
below which additional PEM signatures are required for support.
(2) The HMM approach probably misses weak signals that are
several windows in length in a Markov chain. ERDS therefore
scans through all of the uncalled regions to pick up the segments
with RD ratios (observed RD to expected RD) that are smaller than
a certain threshold and searches for supporting PEM signatures
nearby to generate additional deletion calls. (3) For a putative
deletion, whenever PEM or SC signatures are available, ERDS
employs the signatures to refine the boundaries.
Genotyping
ERDS calculates the integer copy number of every region on the
basis of the ratio of the observed RD to the expected RD. ERDS
then outputs regions where the inferred copy number of the
sequenced sample is different from the absolute copy number of
the reference genome. Defined deletions and duplications in non-
amplified regions are based on the assumption that the reference is
diploid, whereas in amplified regions the type is determined rela-
tive to the absolute copy number of the reference genome for the
aggregated set of regions.
PCR Validation and Sanger sequencing
We used the reference genome sequence (300 bp both 30 and 50 of
the deletion) to design primers that flank the putative deletion.We
then amplified each deletion in the test samples and ran them out
on a 1% agarose gel to verify the size for each test sample in a given
primer set.
We then used Sanger sequencing to sequence the PCR product
of the deletion regions in each test sample (forward and reverse)
and determined whether the deletion was in fact present. For an
amplified deletion, we checked that its product size matched the
expected size in those predicted to have and to lack the deletion.
When the amplifications were of the correct sizes, we concluded
that the sizes matched and that the sequencing confirmed the
deletion. Otherwise, we concluded that the sizes did not match
and that the sequencing could not detect a deletion.Results
Here and throughout the paper, we consider a stringent
50% reciprocal overlap criterion to declare that two CNV
calls are the same. We chose to use UCSC SD regions in
the evaluations instead of the amplified regions (BWA-
indistinguishable regions) derived from the ERDS algo-
rithm because UCSC SD regions are publically available;
thus, the evaluations could be performed without refer-
ence to ERDS, and the results of comparisons would not
be unfavorable to other tools. Regions not overlapping
SDs are termed unique regions. When 50% or more of
a region is covered by SD regions cumulatively, we say
that region is in SD regions. We focused our evaluations
on CNVs in unique regions or SD regions; a small category
of regions that were intermediate, modestly overlapping410 The American Journal of Human Genetics 91, 408–421, Septemb(50% or less) SD regions were not considered. Sources for
all data sets are provided in the Web Resources.
Evaluation of the 1000GP Release Set in NA12878
One challenge in comparing CNV calling methods is that
the true pattern of CNVs is difficult to accurately charac-
terize in any genome.3,17,29 It is therefore necessary to
compare methods by using calls that are known to be
only partially accurate. One important reference data set
for making such comparisons is the 1000GP ‘‘release set’’
in Mills et al.15 We therefore first carried out a careful eval-
uation of this set of calls in sample NA12878 by using
publicly available data, including alignment files, SNV
files, and parents’ SV data (Web Resources).
Our evaluations of the 1000GP release set (Figure 2;
Appendix B) were limited to all deletions that were both
greater than 1 kb and in unique regions because these are
considered easier to call than SD regions. To evaluate
whether called deletions were likely to be real, we consid-
ered several key data points, as outlined in Appendix B.
In particular, we considered whether a putative deletion
was seen in the parents of the subject considered, what
the RD ratio was, and critically, whether there were many
heterozygous SNVs in the region of the putative deletion.
Using these simple assessment approaches, we found
that in the release set, the FDR was 8% (95/1197) for dele-
tions larger than 1 kb, 38% (80/212) for deletions larger
than 10 kb, and a very high 77% (44/57, Table S1 in the
Supplemental Data available with this article online) for
deletions larger than 100 kb (Table 1). A goal of the
1000GP was to create a release set with an FDR % 10%.15
Our analysis showed, however, that the FDR is very
unevenly distributed with respect to deletion size and
that it is substantially higher for larger deletions. The
high FDR for the largest deletions appears to be due to
the dependence on PEM signatures, which become less
reliable with increasing deletion sizes.16,17
This evaluation suggests that the difficulty of detecting
deletions accurately might have been underestimated
and that there is considerable room for improvement of
algorithms. This assessment also showed the importance
of using RD information and SNV heterozygosity effec-
tively in the inference of deletions. These two components
are incorporated in the ERDS framework.
Evaluation of ERDS-Called Deletions
The comprehensive evaluations in Mills et al.15 demon-
strated that Genome STRiP,18 which provided the lowest
FDR of all the approaches included in that study, is the
most sensitive tool for calling deletions in a low-coverage
sample and that CNVnator30 is the most sensitive tool
for calling deletions in a high-coverage sample. We there-
fore sought tomake direct comparisons of the performance
of ERDS with Genome STRiP and CNVnator. No evalua-
tions of the performance of Genome STRiP on high-
coverage samples have been released.15,18 Because Genome
STRiP requires 20–30 genomes to reliably detect variants,er 7, 2012
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Figure 2. RD Assessment of Deletions in Unique Regions in the Release Set
RD ratios for regions were calculated as the ratio of the observed RD to the expected RD according to the Gþ C percentage. A ratio of 1.5
or smaller in unique regions suggests a deletion; confidence increases as the RD ratio decreases and the length of the region increases.
Histograms of counts with respect to RD ratios were plotted for different categories with a bin width of 0.1. Different sizes are compared:
(A) those larger than 1 kb (n ¼ 1197) and (B) those smaller than 1 kb (n ¼ 3385). For deletions larger than 1 kb, (C) those that failed the
heterozygosity check (n ¼ 163) and (D) those that passed the heterozygosity check (n ¼ 1034) are shown. With regard to the deletion
results in the parents, (E) those that are putative de novo (n ¼ 378) and (F) those seen in one of the parents (n ¼ 819) regardless of
zygosity are shown.we sequenced NA12878 at ~403 in our center so that
we could apply Genome STRiP (version 1.04.785) to
NA12878 together with 24 other high-coverage samples
sequenced in our center, and we also applied CNVnator
(version 0.2.2) and ERDS (version 1.04) to call deletions
(Table S2). We calculated the sensitivity of each approach
in various size classes by using the GSD in Mills et al.15
(Figure 3A). We broke down the data sets into size cate-
gories of <400 bp, 400 bp–1 kb, 1–10 kb, 10–100 kb and
R100 kb. We needed to include the category of <400 bp
to account for the abundant deletions caused by alu inser-
tions in the reference genome, although apparently such
deletions are underrepresented in the GSD.31 In general,
Genome STRiP performed well in each length category,
whereas CNVnator was most sensitive for large deletions.
ERDS identified 70% of the deletions among a total of
3491 predictions (Table S3) and achieved a sensitivity
12% greater than that of the other two methods. ERDS re-
mained the most sensitive method when we relaxed the
overlapping criterion to a 1 bp overlap (Table S4). ERDS
also performed well in SD regions (Table S5).The AmericanBecause deletions in unique regions in the GSD should
be more reliable than those in SD regions, we sought to
evaluate the positive predictive value (PPV) of a call set
only in unique regions, as defined by x/y, where x predic-
tions in a call set overlapped with the GSD among y predic-
tions in a given size range. As expected, Genome STRiP
achieved the highest overall PPV (Table 2), consistent
with its lower FDR.15,18 ERDS showed PPVs almost iden-
tical to those of Genome STRiP in many categories. PPVs
were nearly zero for all call sets for deletions smaller than
400 bp, mainly because small deletions were underrepre-
sented in the GSD. If we restrict the evaluation to deletions
larger than 400 bp, where the distribution of counts in
GSD is presumably more accurate, then ERDS showed
a PPV (0.28) slightly higher than Genome STRiP (0.26). It
is also clear that the high sensitivity of CNVnator is
achieved at the cost of a dramatically lower PPV (0.02).
Because theGSD generally under-called variants, particu-
larly small ones, we also calculated the PPV by using the
release set as the gold standard by which to compare ERDS
with Genome STRiP and CNVnator. In this comparison,Journal of Human Genetics 91, 408–421, September 7, 2012 411
Table 1. Percentage of Deletions in the 1000GP Release Set that Failed According to Different Evaluation Approaches or Their
Combinations
Category
Putative
De Novo (A) RD Ratio > 1.5 (B)
Violation of SNV
Heterozygosity (C) (A) & (B) (A) & (C) (B) & (C) (A) & (B) & (C)
1 kb þ (n ¼ 1197) 32% 44% 14% 21% 9% 11% 8%
10 kb þ (n ¼ 212) 67% 66% 50% 54% 40% 45% 38%
100 kb þ (n ¼ 57) 93% 93% 84% 88% 79% 82% 77%
The analysis was limited to unique regions.ERDS showed the highest overall PPVand the highest PPVs
in many categories, including the size category of <400 bp
(Table 2). The overall PPV is 0.7, and this can be explained
by the incompleteness of the release set.
Most examples of confirmed pathogenic CNVs are rare
not only in population controls but also among the cases
studied, consistent with the greater functional impact of
rare CNVs.3 For this reason, it is of particular importance
that any CNV calling method performs well for rare
CNVs. In one of the largest CNV studies to date,3 CNV gen-
otyping arrays were used for the detection of CNVs from
180 CEU samples, including NA12878. For the deletions
observed in NA12878, we considered all those that were
called in no more than 1%, 2%, or 5% of the considered
samples, and we compared the performance of alternative
calling methods among this critical set of rare deletions.
We found that for all frequency cutoffs, ERDS had higher
sensitivity than Genome STRiP and CNVnator: it called
somewhere between 6% and 11% more deletions than
the next-best method (Figure 3B).
To annotate the likely functional effects and potential
clinical significance of a CNV, a method must not only
detect the presence of a CNV but also accurately determine
its breakpoints. ERDS achieves high breakpoint resolution
as a result of the integration of PEM and SC signatures
(Figure 4). We observed that ERDS provided 1,000 more
deletions that exactly matched the breakpoints of dele-
tions in the release set than did Genome STRiP or
CNVnator. This is because the current versions of Genome
STRiP and CNVnator do not incorporate SR or SC features
in their approaches.
Evaluation of ERDS-Called Duplications
Sample NA18507 is another widely studied sample.20,23We
also sequenced this sample to ~403 coverage and applied
CNVnator and ERDS to call CNVs. When the duplication
calls identified by a hybrid genotyping array20 were used
as the gold standard, ERDS showed slightly higher sensi-
tivity for duplications than did CNVnator for both
NA12878 and NA18507 (Table S6). Note that the overall
sensitivity for duplications (approximately 50% in this
evaluation) is lower than that for deletions (approximately
70% in the previous section) when NGS data are used,
reflecting the increased difficulty in detecting duplications.
To further evaluate duplication calls from ERDS both for
sensitivity and specificity, we sought to compare gene copy412 The American Journal of Human Genetics 91, 408–421, Septembnumbers derived from mrFAST and mrsFAST alignment
results for sample NA18507 (Sudmant et al.,14 Alkan
et al.,23 and Can Alkan, personal communication). Because
of the fundamentally different ways in which the aligners
handle reads from repetitive regions, a direct comparison
of copy-number calling in ERDS versus the mrFAST
and mrsFAST framework is not possible, and an adjust-
ment is required. For all genes, after this adjustment
(Appendix C) to account for the difference caused by
read lengths and aligners, the correlations between the
adjusted ERDS result and mrFAST’s (Pearson correlation
coefficient r ¼ 0.66) or mrsFAST’s (r ¼ 0.68) results ap-
proached the correlation between mrFAST’s and mrsFAST’s
results (r ¼ 0.84) (Figure S2).
Genotyping Accuracy
We sought to assess the accuracy of the genotyping results
from ERDS. McCarroll et al. assigned copy numbers to
samples on the basis of the ratio of the intensity
values.20 We used this data set to assess whether ERDS,
having identified the type of a CNV (deletion versus dupli-
cation), can also predict the genotype (copy number). For
samples NA12878 and NA18507, we found a high concor-
dance rate for deletion calls but a lower concordance rate
for duplications (Table S7). In rare cases, homozygous dele-
tions were classified as heterozygous deletions, and vice
versa. When restricted to unique regions, the concordance
rates reached as high as 100% for both deletions and dupli-
cations in both samples.
Experimental Validations
The experimental validations were limited to deletions.
Our comprehensive analysis on PPV had already computa-
tionally confirmed high confidence in the accuracy of
ERDS calls.
Our strategy was to target the vulnerable calls, defined as
the ERDS deletion calls that did not overlap with the
release set, the GSD, or the Genome STRiP or CNVnator
call sets in NA12878. Note that such vulnerable calls
only comprised 27% (n ¼ 936) of ERDS-called deletions.
We further limited the validation to those deletions
smaller than 2 kb (n ¼ 698, 12% in SD regions) to increase
the likelihood of a successful PCR assay. We have already
determined that ERDS has higher PPV for larger deletions
in general (Table 2). A subset of 23 calls (three in SD
regions) were randomly chosen for performing PCRer 7, 2012
Figure 3. Sensitivity Measurements for Different Approaches
The criterion of 50% reciprocal overlap was used (A) for calling
deletions in NA12878 in the GSD from Mills et al. in different
size classes and (B) for calling rare deletions in NA12878 with pop-
ulation frequencies of less than 1%, 2%, or 5% in Conrad et al.3validations and Sanger sequencing from the 698 calls
meeting the described inclusion criteria for validation
(Table S8). For each of the vulnerable calls, we used one
negative and one positive control sample. Primer design
failed for two of the selected deletions. For the remaining
21 that were successfully analyzed, two had no amplifica-
tion and two had incorrect product sizes. The other 17
(81%) have amplifications of the expected sizes, and
Sanger sequencing confirmed the calls (Material and
Methods).
We also performed validation by using TaqMan quanti-
tative rtPCR assays. For this validation, we chose seven
ERDS calls that were missed either by PennCNV32 or Break-
Dancer33 in some of our samples. These deletions are larger
than the deletions selected for PCR validation (median
length is 20 kb). The TaqMan assays were commercially
available on-demand assays through Applied Biosystems.
For each selected deletion, we used the TaqMan assay
targeting a gene within the deletion to ascertain the copy
number in approximately 85 individuals, including the
sample with the suspected CNV. The CNV was validated
if the subject with the ERDS-called deletion was also found
to harbor a deletion of the representative gene by the
TaqMan assay. Two of the seven TaqMan assays failed to
amplify the targeted DNA sufficiently to achieve accurate
quantitative measurements and were therefore excludedThe Americanfrom the analysis. Of the five reliable assays, four clearly
confirmed the ERDS call. The deletion not validated by
TaqMan is located in an SD region, where there is a paralo-
gous sequence with 99.6% similarity. The TaqMan showed
CN ¼ 2 and thus no deletion. However, because the refer-
ence has four copies of this region and the TaqMan assay
only showed CN ¼ 2, we can infer that the ERDS’s deletion
call is correct. Therefore, all deletions were validated when
copy numbers were compared to those for the reference
genome (Table S9).Discussion
We have developed a tool called ERDS for detecting dele-
tions and duplications. Importantly, ERDS uses the same
alignment data (the BAM file) that are used for calling
SNVs and INDELs, so that the computational burden
remains manageable even for large studies. ERDS currently
supports NCBI reference genome builds 36 and 37 and can
be easily updated to future builds as they become available.
Currently, on a PC with 8G memory, it can call CNVs for
a sample with 403 coverage within 10 hr.
Using the same alignment file, we compared the perfor-
mance of ERDS to two existing CNV-calling software tools,
Genome STRiP and CNVnator, which appear to be the
strongest alternative approaches available. The perfor-
mance of each algorithmwas affected bymultiple complex
factors, including coverage, library size, and read length.
Overall, these direct comparisons showed that there are
no CNV types for which ERDS performs worse with regard
to high-coverage genomes. Genome STRiP, in particular,
generally performs very well, but its performance clearly
fell for the rarest deletions as compared to ERDS. However,
ERDS performs at least as well as Genome STRiP for all
other conditions as long as the genomes are sequenced
to a coverage of at least 103. For genomes sequenced at
lower coverage, we recommend the use of Genome STRiP
over ERDS (Table S10). We also note that ERDS analyzes
one genome at a time, whereas Genome STRiP infers
CNVs in population-scale sequencing data. It is possible
that Genome STRiP offers some advantages in detecting
structural variants that occur in multiple individuals in
a data set, whereas ERDS will be superior in the detection
of rare structural variants. We did not systematically eval-
uate the consequences of this difference in approach,
however. Although Genome STRiP and CNVnator appear
to be the strongest approaches currently available, ERDS
does share some features with CNVer.22 We therefore also
compared the performance of ERDS to CNVer and found
that ERDS performs better for all classes of CNVs (Tables
S6 and S11).
ERDS is also accurate at defining breakpoints for small
deletions, and it reaches nucleotide resolution for many
calls. Genotyping results of ERDS show excellent concor-
dance with SNP array and FISH results (Table S12). Addi-
tionally, comprehensive computational evaluations andJournal of Human Genetics 91, 408–421, September 7, 2012 413
Table 2. PPVs for Deletions in Unique Regions in Different Size Categories
GSD as the Gold Standard
Category
<400 bp
(n ¼ 57)
400 bp-1kb
(n ¼ 79)
1–10 kb
(n ¼ 334)
10–100 kb
(n ¼ 56)
R 100 kb
(n ¼ 2)
Overall
(n ¼ 528)
R 400 bp
(n ¼ 471)
Genome STRiP 1j186j0.01 51j436j0.12 201j576j0.35 21j30j0.70 1j1j1.00 275j1229j0.22 274j1043j0.26
CNVnator 4j837j0.00 7j3464j0.00 194j7001j0.03 27j158j0.17 1j33j0.03 231j11493j0.02 228j10656j0.02
ERDS 13j1724j0.01 52j429j0.12 223j626j0.36 28j39j0.72 1j1j1.00 317j2819j0.11 304j1095j0.28
The Release Set as the Gold Standard
Category
<400 bp
(n ¼ 2772)
400 bp–1 kb
(n ¼ 613)
1–10 kb
(n ¼ 985)
10–100 kb
(n ¼ 155)
R 100 kb
(n ¼ 57)
Overall
(n ¼ 4582)
Genome STRiP 115j186j0.62 222j436j0.51 453j576j0.79 26j30j0.87 1j1j1.00 817j1229j0.66
CNVnator 221j837j0.26 183j3464j0.05 577j7001j0.08 37j158j0.23 2j33j0.06 1020j11493j0.09
ERDS 1173j1724j0.68 244j429j0.57 485j626j0.77 34j39j0.87 1j1j1.00 1937j2819j0.69
In the rows of categories, n represents the number of calls in the gold standard in a size range. The main cells are in the format of AjBjC, where A is the number of
predictions that overlap the gold standard in a call set, B is the number of predictions in a particular size range in a call-set, and C is the PPV defined by A/B. Note
that A is also an indication of sensitivity.validations by PCR, Sanger sequencing, and TaqMan assays
suggest that ERDS has a low FDR for deletions. Compared
to that for deletions, the evaluation of called duplications
was relatively weaker, because of both the lack of good
reference and the technical difficulty of the experimental
validations.
To compare ERDS with Genome STRiP and CNVnator,
we sequenced two well-studied samples at high coverage,
mainly because the evaluation of Genome STRiP on
high-coverage samples was not publicly available and we
needed to make the calls together with other samples
sequenced at high coverage on the same sequencing plat-
form. For the evaluation of the deletions in NA12878 in
the release set in Mills et al., we only used publicly avail-
able data. For unique regions, in this evaluation we found
that the larger a call, the less reliable it was.When applying
these evaluations to Genome STRiP and ERDS in NA12878,
we found that both approaches showed better accuracy
than did the 1000GP release set (Table S13), in part because
of the integration of multiple signatures into their calling
frameworks. However, this improvement should also be
acknowledged to be in part due to the improvement in
the sequencing technology. The 1000GP itself will also
have updated the calls with improved algorithms. Our
evaluation of the 1000GP release set was limited to a single
high-coverage sample; we did not attempt any evaluation
of the low-coverage data.
Although many promising methods for CNV calling
have emerged, many challenges remain. For example,
certain large regions with extraordinary structural com-
plexity14 confound current approaches. For example,
duplications called by ERDS could be insertions at
unknown genomic locations; identification of their
precise locations therefore needs further work, possibly
involving the incorporation of PEM information or other
approaches. Sensitive detection of inversions and accurate
inference of breakpoints of big deletions as well as duplica-414 The American Journal of Human Genetics 91, 408–421, Septembtions remain technically difficult. Improved tools that
combine multiple signatures by starting from PEM signa-
tures and SR features and then assessing the calls by using
RD information to infer deletions accurately (essentially
the reverse of the approach used here) are currently under
development (Y.H., unpublished data). In theory, this
approach can detect multiple types of complicated SVs,
including insertions, translocations and inversions, across
a wide range of sizes. Of note, sensitive and accurate detec-
tion of CNVs from exome sequence data are clearly more
difficult, although tools such as CoNIFER34 show signifi-
cant progress.
In summary, ERDS is generally as good as any existing
CNV-calling method and is superior in the key category
of rare CNVs. When this approach is combined with the
computational convenience of using the same alignment
data as those used for calling other types of variants,
ERDS appears to be one of the best all-around choices
currently available for CNV calling in high-coverage
samples, in particular for the detection of rare pathogenic
CNVs in human disease.Appendix A: Algorithm Development in ERDS
Identification of Amplified Regions in the Reference
Genome
We simulated reads with lengths of 100 bp evenly across
the reference genome and aligned them to the reference
by using BWA with the option of mapping a read at up
to 10,000 different locations. For each 1 kb region, if
another region of similar length contributed reads of
which more than half could be mapped to the current
region, then that region was viewed as being paralogous
to the current region. The sequences from these two
regions usually had an overall identity that was greater
than 0.99. The region and all of its paralogous regionser 7, 2012
So-clipped reads where only heads were 
aligned, indicang the precise start of a SV
So-clipped reads where only tails were 
aligned, indicang the precise end of a SV
Other reads where only 
one end was mapped
Paired-end reads 
mapped properly
Paired-end reads 
with abnormal 
distance indicang 
deleons
RD plot
Le boundaries
GSD: 65179255
ERDS: 65179256
Genome STRiP: 65179250
CNVnator: no call
Right boundaries
GSD: 65181405
ERDS: 65181405
Genome STRiP: 65181408
CNVnator: no call
Figure 4. Breakpoint Resolutions of CNV Calls for a Deletion at chr10: 65179255–65181405 from the GSD.15
The top panel is plotted with SVviewer (Y.H., unpublished data) for displaying the aligned reads at region chr10: 65179255–65181405
along with 1 kb flanking regions at both sides. Both the PEM and SC signatures are integrated into the ERDS framework, making it
possible to reach bp resolution in the breakpoint inference. The bottom panel is the RD plot for the same region. Although the RD
was depleted in the middle, clear breakpoints were hard to indentify, in particular on the left-hand side. ERDS made a call at chr10:
65179256–65181405, which differed by 1 bp for the left breakpoint and matched the right breakpoint. Genome STRiP called the dele-
tion at chr10: 65179250–65181408, which differed by 5 bp for the left breakpoint and 3 bp for the right breakpoint. CNVnator did not
call this deletion.were viewed as a set whose members could not be distin-
guished by BWA. We identified all paralogous regions
throughout the reference genome and marked them as
amplified regions.
The insertion size and read lengths will vary somewhat
from sample to sample, and this will influence whether
specific parts of the genome can or cannot be accurately
aligned with BWA. Computational limitations restrict the
ability to perform such an assessment specifically for
each sample considered, and it is unlikely to be necessary.
The aim of this step is simply to create a refined version of
the UCSC SD regions, refined in the sense that we directly
assess (approximately) which parts of the genome are and
are not mappable by BWA. It is also important to appre-
ciate that the purpose of identifying the amplified regions
is to determine where to call locus-specific copy numbers
or genome-wide summed copy numbers (absolute copy
numbers). A further consideration is that if the amplified
regions are identified in a sample-specific manner, then it
is hard to compare the CNV results across sets of cases
and controls in association studies.
G þ C Correction
In the evaluation of the 1000GP release set, for each dele-
tion we randomly found 20 other regions that have the
same length and G þ C percentage. We then determinedThe Americanthe expected RD to be the median RD of these 20 regions.
This analysis is completely independent of ERDS work.
In the ERDS framework, the RD for each 200 bp sliding
window throughout the autosomes was calculated from
the BAM file. Included was a noise-removing step that dis-
carded loci in each window with extreme RD. Windows
were grouped into 101 bins on the basis of their G þ C
content.
Our G þ C estimation method is different from existing
methods.23,35 We sought to estimate the RD for the diploid
state (normal state) in every bin. Note that a method in
Yoon et al.35 simply took the average RD of the whole
bin. For a bin with T members, we adopted this approach
if T < 200. We employed an EM algorithm26 to estimate
the expected RD when T R 200. We assumed that the
RD values in a bin were from a mixture of N Poisson distri-
butions13,16,36 corresponding to N copy-number states. Let
Ot be the RD of the t-th windows and zt be the latent vari-
able, where zt ¼ i indicates that Ot belongs to the i-th copy-
number state. Let the RD distribution from the i-th state be
pðOt j zt ¼ iÞ  e
lilOti
GðOtÞ ;
where li corresponds to the mean RD of the i-th
copy-number state and G() is the Gamma function.Journal of Human Genetics 91, 408–421, September 7, 2012 415
We defined ci ¼ p(zt ¼ i) and deduced the following EM
algorithm:
E step
bc i ¼
PT
t¼1
pðOt ; liÞCiP5
j¼1
p

Ot ; lj

Cj
T
and M step
blt ¼
PT
t¼1
pðOt ; liÞCiP5
j¼1
p

Ot ; lj

Cj
Ot
PT
t¼1
p

Ot ; lj

CiP5
j¼1
p

Ot ; lj

Cj
;
where 0t is the RD of the t-thmember and ci is the marginal
probability of state i. After initial estimations of li and ci, bli
and bc i were updated by this formula and eventually
converged.bl3ðsÞ is considered to be the expected RD for the
windows with G þ C percentage s. Because sample sizes
for other states are relatively small in comparison to
that for the normal state, we estimated other values of bli
simply by scaling
dlis3 ¼ i
2
,bl3:
Paired HMM at Nonamplified Regions
HMMs27 have been employed for calling CNVs from
various types of data.13,19,32 In this study, we viewed the
RD of consecutive windows and heterozygosity informa-
tion as a paired chain of observations, and we viewed the
underlying copy numbers of windows as the hidden states.
Considering that the RD can be any nonnegative rational
number, we used a continuous paired HMM.
We defined n þ 2 states representing CN ¼ 0, ., n þ 1.
State n represents a collection of windows whose true
copy number is at least n (n is suggested to be a number
between 4 and 10; here, we used 6). We further created a
‘‘dummy’’ state n þ 1, which represents windows at ampli-
fied regions or contig gaps. This state serves as a connector
to make disconnected chains into a longer chain. Mean-
while, we kept the state from affecting the parameter
estimation by assigning equal values to the transition
probability for each state.
Emission Probabilities for RD
We estimated probability by using a Poisson distribution,
pðOt j zt ¼ iÞ  e
bl t ðsÞbliðsÞOt
GðOtÞ ;
where s is the GþC percentage of the window under study
and bliðsÞ was derived from the previous EM algorithm’s
G þ C correction.416 The American Journal of Human Genetics 91, 408–421, SeptembMany noisy signals arose from repetitive regions that
were not large enough to be characterized as amplified
regions. The mapping qualities at those regions were
usually low, and the RD signals were less reliable. We
adjusted the emission probability for the t-th observation
by multiplying by a weight
wt ¼ MQt
MQmax
;
where MQt is the mapping quality of the current window
and MQmax is the maximum value used in the mapping-
quality scores. In NA12878, about 92% of the alignable
regions (the whole reference genome excluding N regions)
have wt R 0.9. This is a heuristic and computationally
inexpensive approach that ensures that the inference on
one window with a poor mapping quality is based less
upon its RD and more upon the RD of its neighboring
regions with higher mapping qualities or upon a chain of
windows with low mapping qualities that together can
increase the signal.
Emission Probabilities for SNV Heterozygosity
Heterozygous SNVs were extracted from the variant file,
which was either in SAMtools pileup format37 or in vcf
format.38 We implemented a probabilistic approach to
deal with possible errors of SNV calling or boundary issues.
At the t-th window found to contain Ht > 0 heterozygous
SNVs, we assigned a probability of c1ðHtÞ ¼ 102Ht
if the hidden state was a one-copy deletion and
c0ðHtÞ ¼ 103Ht if it was a two-copy deletion. The proba-
bilities for other states were set to be equal to each other
(and thus played no role in the decision-making process).
ciðHtÞ ¼
8><>:
10i3Ht ; i ¼ 0;1
ð1 c0ðHtÞ  c1ðHtÞÞ
10
; iR2:
We used these emission probabilities to penalize the
heterozygosity at the regions of deletions. These parame-
ters were fixed and free from updating in the Baum-Welch
algorithm. More accurate modeling of the emission proba-
bilities is difficult because of the noise carried in real data.
Transition Probabilities Matrix
We applied a modified Baum-Welch algorithm to update
the transition probability matrix. The induction formula
20 in the forward procedure in a paper by Rabiner27
becomes
atþ1ðiÞ ¼
"XN
j¼1
atðiÞaij
#
p

Ot ; lj

cjðHtÞ:
The induction formula 25 in the backward procedure
becomes
btðiÞ ¼
XN
j¼1
aij p

Ot ; lj

cjðHtÞbtþ1ðjÞ:er 7, 2012
Formula 40b becomes
aij ¼
PT1
t¼1;Otsnull
xtði; jÞ
PT1
t¼1;Otsnull
gtðiÞ
:
We set the initial state probability to be the initial
marginal probability of state i.
Paired Viterbi Algorithm and CNV Calling
We employed the Viterbi algorithm27 to find the most
likely chain of states (copy numbers). Because we had
two sets of emission probabilities, we added an extra
term coding for the second matrix to the initialization
and recursion steps. Precisely, the formulas 32a and 33a
in the Rabiner paper27 were modified to be
d1ðiÞ ¼ pibiðO1ÞciðH1Þ; 1%i%N
and
dtðjÞ ¼ max1%i%N

dt1ðiÞaij

bjðOtÞcjðHtÞ; 1%j%N; 2%t%T ;
where cj(Ht) is the probability of seeing a case of SNVs Ht
given state j.
The windows of the null or normal state were excluded.
Consecutive windows with the same copy numbers were
then merged.
Refinement for Deletions
(1) For a putative deletion smaller than 10 kb, ERDS
requires the support of the PEM signature (insert
size > average library size þ 3 SD). When the dele-
tion is larger than 1 kb, ERDS requires one pair to
support the deletion, and when it is smaller than
1 kb, ERDS requires two pairs. Users can adjust these
parameters according to the coverage of a sample. A
k-means clustering algorithm served to cluster the
abnormally mapped paired-end reads and find the
cluster that most supports the putative deletion.
Suppose that p pairs of abnormal reads were found
nearby and the requirement was q pairs; the algo-
rithm would iteratively partition the pairs into k
clusters, where k was defined as the least integer
larger than p/q. Each pair was assigned to an initial
cluster randomly. For each cluster, its mean is
defined as (lm, rm), where lm (or rm) is the mean value
of the left (or right) breakpoints of its members. In
the next iteration, each pair was grouped to the
nearest cluster. The distance from a pair with a left
breakpoint l and a right breakpoint r to a cluster
with mean (lm, rm) was defined as jl  lmj þ jr  rmj.
After a certain number of iterations (ten here), very
few clusters, but at least one (Pigeonhole principle),
would have members greater than or equal to q.
Finally, for each cluster only the members with
a distance that is less than the mean inner library
size (defined as the mean library size  2 3 readThe Americanlength) were kept. The one with the highest product
of the number of members in the cluster and the
rate of the region defined by the cluster overlapping
with the putative deletion region was then chosen
to support the deletion. Here, k was set reasonably
high so that the output cluster would be a true set
of supporting signatures.
(2) The HMM approach tends to miss weak (several-
windows long) signals in a Markov chain mainly
because of the penalty of the transition probabilities
in an HMM. ERDS then scans through the whole-
genome to pick up the segments with RD ratios
(observed RD to expected RD) that are smaller
than a threshold (for example, at 403 coverage,
a window with RD ratio ¼ 1.3 would be determined
to represent a single copy by the Poisson model,
whereas a window with RD ratio ¼ 1.4 would be
determined to be two copies) and checks whether
there are PEM signatures overlapping this region
(at least 3 pairs of PEM signatures are required) to
generate additional deletion calls. Again, the param-
eters can be user specific.
(3) For a putative deletion, when PEM or SC signatures
are available, ERDS uses them to refine the break-
points. The SC signature is denoted as ‘‘S’’ in the
CIGAR column in a BAM file, indicating that
a read has only been partially (the head or tail) map-
ped to the reference. A locus covered by two ormore
SC signatures within 200 bp of a breakpoint of
a putative deletion is used to support that deletion.
In this step, many of the parameters were heuristic.
Determination of the right set of parameters is always chal-
lenging because the true parameters are unclear or may not
even exist. We selected parameters that were representative
of different size categories, but users can optionally specify
them in the command.
Genotyping
For the absolute copynumber for eachCNVERDS called,we
assigned an integer copy number on the basis of the ratio of
the observed RD to the expected RDwith respect to the Gþ
C percentage. However, the copy number of an arbitrary
region (gene region, FISH region, etc.) is the weighted
meanvalueof the copynumberswhenall deletions, normal
regions, and duplication regions covering the region are
taken into account. If we consider the reference genome
as a sample, the absolute copy number of a region is esti-
mated by theweightedmean value of nonamplified regions
(copy number ¼ 2) and amplified regions (copy number is
twice the number of indistinguishable paralogous regions).
Appendix B: Evaluation of the 1000GP Release Set
in NA12878
The release set contains deletions and insertions for more
than 180 samples, including a majority of low-coverageJournal of Human Genetics 91, 408–421, September 7, 2012 417
samples and a few high-coverage samples.15 Here we only
focused on the deletions in the high-coverage sample
NA12878. Of note, Genome STRiP was not applied to
this sample.15,18
In this evaluation we limited our assessment to 1,197
deletions that were both larger than 1 kb and in unique
regions (23% of a total of 5275 deletions) for higher confi-
dence. First, we separated deletions in NA12878 into two
groups: inherited (seen in either of the parents’ deletion
results regardless of the zygosity) and putative de novo
(others). Strikingly, 32% (n ¼ 378) were found to be puta-
tive de novo. We can conclude that almost all of these
putative de novo deletions were either false-positive calls
in the child or false-negative calls in the parents, in part
because of the multiple discrepancies both between the
algorithms and between sequencing technologies.
We then assessed these deletions by using RD informa-
tion from the alignment file originally used for inferring
the deletions. For each deletion, we calculated its normal-
ized RD ratio, that is, the observed RD adjusted by the ex-
pected RD according to the GþC percentage (Material and
Methods), and multiplied by 2. A ratio of 1.5 or less in
unique regions is suggestive of a deletion, and the smaller
the RD ratio, the more confidently a deletion can be pre-
dicted. Similarly, the longer a region, the more reliable
the RD ratio is. To reduce possible noise caused by
boundary effects, we only counted the RD in the internal
region; we excluded 10% on each side. We observed that
38% (454/1197) of the deletions in the release set had
RD ratios larger than 1.5. A significant proportion of calls
were centered at the peak RD ratio of 2 in the frequency
histogram (Figure 2A), indicating no presence of deletions.
More surprisingly, of those deletions larger than 10 kb and
100 kb in the release set, 66% (140/212) and 93% (53/57),
respectively, had RD ratios greater than 1.5. We also calcu-
lated the RD ratio for those that were both smaller than 1
kb and in unique regions for a comparison. Although the
correction for G þ C bias is presumably less effective for
small deletions, we were still able to find a peak at RD ratio
¼ 1 and a long, thin tail toward larger ratios (Figure 2B).
A deletion in a unique region of an autosome means
that, at most, one copy of the region is present in the
genome; the deletion region should therefore not contain
any heterozygous SNVs. SNV data from the 1000GP pilot
data were used for this assessment. To account for possible
boundary effects and potential SNV-calling errors in noisy
real data, we only counted SNVs in the internal 80% region
and considered a deletion to be supported if (1) it con-
tained no more than two heterozygous SNVs or (2) no
more than 20% of the SNVs were heterozygous. Consid-
ering that on average every 1 kb genomic region contains
less than 1.2 SNVs,39,40 many putative deletions regions
would meet the first criterion even if no deletion were
present. Therefore our heterozygosity check is a most-
permissive possible assessment, and it probably only
provides the lower bound of the FDR. Restricting deletions
to those larger than 1 kb, 14% of deletions in the release set418 The American Journal of Human Genetics 91, 408–421, Septembfailed the heterozygosity check, and the majority of them
had an RD ratio centered at 2 (Figure 2C), further indi-
cating a false positive. As a comparison, two peaks repre-
senting homozygous and heterozygous deletions were
clearly present in the plot for those that passed the hetero-
zygosity check (Figure 2D). The failure rate for deletions
larger than 10 kb (or 100 kb) is 50% (or 84%).
For the putative de novo deletions described above,
27.8% (n ¼ 105) failed the heterozygosity check, and
58.2% (n¼ 220) had RD ratios greater than 1.5. In contrast,
7.1% (n ¼ 58) of those inherited from parents failed the
heterozygosity check, and 28.6% (n ¼ 234) had RD ratios
greater than 1.5 (Figures 2E and 2F).
It is reasonably safe to assume that a putative deletion
called de novo and failing both the RD assessment and
the heterozygosity check is incorrect. In this case (Table
S1), the FDR in unique parts of the genome is 8% (95/
1197) for deletions larger than 1 kb, 38% (80/212) for dele-
tions larger than 10 kb, and 77% (44/57) for deletions
larger than 100 kb (Table 1). Although the number of these
false deletions is small because we focused on unique
regions and applied the most stringent criteria in deter-
mining false calls, they made up approximately 22% of
the whole call set in terms of genomic length and affected
13% of genes among those affected by the overall call set.
This is because the FDR in the larger size category is higher.
One obvious question is why the FDR is so high for large
deletionsdespite the careful attention toFDRof the contrib-
uting methods and the extensive use of experimental vali-
dation. Upon inspection, we found that approximately
96% (55/57) of those deletions larger than 100 kb were
contributed by PEM or SR methods. This finding clearly
explainspart of thepuzzlebecause thePEMandSRmethods
are known to be increasingly less reliable for large deletions,
presumably as a result of the reduced accuracy of aligners
in placing the pairs of short reads correctly over long
distances.16,17 The data for inferring CNVs in the 1000GP
release set were from multiple centers with different
sequencing platforms and included both single and
paired-end reads generatedwith different insert sizes. These
factors complicated the ability to make accurate calls.
Looking further at the false deletions larger than 1 kb, we
found that each was validated by some approach, indi-
cating that a careful assessment of the experimental valida-
tions is necessary for reducing errors.41 We checked the
pass rate of different validation methods and found that
deletions validated by comparative genomic hybridization
(CGH) array approaches have the highest FDR, whereas
deletions validated by polymerase chain reaction (PCR)
and capture array approaches have nearly zero FDR
(Figure S1). Upon further investigation, we found that
the Nimblegen 2.1M array, chosen as the primary valida-
tion approach among CGH array approaches, was respon-
sible for the majority of the false positives (in particular,
42/44 of false deletions larger than 100 kb). Interestingly,
among all the CGH arrays evaluated by Pinto et al.,41
this array showed the lowest concordance rate betweener 7, 2012
triplicate experiments and the highest FDR required to
achieve a given sensitivity.Appendix C: Evaluations of ERDS-Called
Duplications
Although ERDS is based on BWA alignment, some of the
philosophy behind mrFAST23 and mrsFAST25 has been
integrated to allow improved estimation of the absolute
copy number by summing the read depths from BWA-
indistinuishable segments throughout the genome
(Material and Methods). Because of the fundamental
differences in how reads that can be mapped to multiple
locations are considered, however, it is not meaningful to
make direct comparisons between mrFAST- or mrsFAST-
based copy-number results and BWA-based copy-number
results. The simple reason for this is that whenever regions
can be distinguished in the reference genome, ERDS will
determine copy-number status relative to each distinguish-
able portion of segmental duplication regions, whereas
mrFAST and mrsFAST will combine them. Therefore, as
expected, agreement across all available 17,085 genes was
initially low (Pearson correlation coefficient r ¼ 0.33 for
ERDS with mrFAST and r ¼ 0.34 for ERDS with mrsFAST)
(Figure S2A). Many factors contributed to the discrepancy
between ERDS results and those of mrFAST and mrsFAST.
For example, the alignment files used different sets of
sequence data, and the length of our short reads was
101 bp, but in the previous studies all reads were trimmed
to 36 bp by mrFAST and mrsFAST. It is likely that longer
reads, even if originally distinguishable by an aligner,
may become indistinguishable (even to the same aligner)
after trimming. Thus, for the same gene, the count that
BWA estimated (count_a) as present in the reference
genome was not always identical to the count by mrFAST
or mrsFAST (count_b).
We approximated count_a by using the absolute copy
number of the reference genome in a given region (the gen-
otyping step in the ERDS algorithm), and we approximated
count_b by using publicly available CRG mappability data
(Web Resources). The CRG mappability data show how
many times every 36 bp read can be aligned to the reference
genome with two or fewer mismatches. Repetitive regions
and their flanking regions were masked, consistent with
Alkan et al.23 Intervals in SD (or non-SD) regions contrib-
uting reads that can be mapped to more than 100 (or 10)
locationswere alsomasked. In theory, count_a shouldequal
count_b for every region because both measure how many
times a region shows up in the reference genome. Using
these approximations, we found that count_b is larger
than count_a by 0.5 or more in 9% of the regions; less
than 1% of the time, count_a is larger by 0.5 or more. The
difference in the counts reflected the discrepancy caused
by the different read lengths used. These results suggest
that more paralogous regions were distinguished by BWA
as a result of the longer read length we used.The AmericanFor the purpose of evaluation, we corrected this differ-
ence by dividing the raw ERDS copy number of a gene by
the approximated count_a and multiplied by the approxi-
mated count_b. This simple adjustment seems effective.
For all genes, the correlations between the adjusted ERDS
result and mrFAST’s (r ¼ 0.66) or mrsFAST’s (r ¼ 0.68)
results approached the correlation between mrFAST and
mrsFAST (r ¼ 0.84). Approximately 85% of genes called
as duplicated by mrFAST or mrsFAST were called by ERDS
(Figure S2B); in SD regions, this number increased to
99%. This does not necessarily mean that ERDS was
inaccurate, but rather it means that it was necessary to
compensate for the bias introduced by aligners (among
other factors).Supplemental Data
Supplemental Data include two figures and 13 tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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